Aripiprazole pamoate salt
    1.
    发明公开
    Aripiprazole pamoate salt 审中-公开
    阿立哌唑双羟萘酸盐

    公开(公告)号:EP2497476A1

    公开(公告)日:2012-09-12

    申请号:EP12165213.5

    申请日:2004-07-29

    申请人: Alkermes, Inc.

    CPC分类号: C07D211/52 A61K31/445

    摘要: The invention relates to the discovery that pamoate salt of aripiprazole results in a good to superior long acting and/or extended release profile. Thus, in one aspect of the invention, the invention includes pamoate salt of aripiprazole. Preferably, the pamoate salt is characterized by a ratio of aripiprazole to pamoate of 1:1 or 2:1. The invention further relates to methods of treating an individual in need thereof comprising administering a pharmaceutical composition comprising a pamoate salt of aripiprazole.

    摘要翻译: 本发明涉及发现阿立哌唑的双羟萘酸盐导致良好至优异的长效和/或延长释放曲线。 因此,在本发明的一个方面,本发明包括阿立哌唑的双羟萘酸盐。 优选地,双羟萘酸盐的特征在于阿立哌唑与双羟萘酸盐的比例为1:1或2:1。 本发明进一步涉及治疗有需要的个体的方法,其包括施用包含阿立哌唑的双羟萘酸盐的药物组合物。